PT-141 10mg

Cyclic heptapeptide melanocortin receptor agonist (bremelanotide), derived from Melanotan II. Studied for MC3R/MC4R receptor pharmacology in central nervous system research. Category placement intentionally deferred.

Research Focus:

• Libido & Arousal Research — Studied for pathways associated with sexual arousal and desire in preclinical and clinical literature.

• Central Nervous System Signaling — Investigated for hypothalamic and limbic receptor activity.

• Receptor Pharmacology — Examined for melanocortin receptor binding selectivity.

• Structure-Activity Research — Studied for structure-activity relationships vs. MC1R.

RESEARCH USE ONLY · NOT FOR HUMAN CONSUMPTION

Not for human or veterinary use. Sold exclusively as a reference material for in-vitro and in-vivo laboratory research. Not evaluated by the FDA; not intended to diagnose, treat, cure, or prevent any disease.